The Centers for Disease Control and Prevention today recommended the Moderna and Pfizer bivalent COVID-19 vaccines in children as young as 6 months old. The Food and Drug Administration yesterday authorized for emergency use  the Moderna vaccine as a single booster dose for children aged 6 months through 5 at least two months after primary vaccination, and the Pfizer vaccine for children aged 6 months through 4 who have not yet received the third primary series dose. With the CDC recommendation today, health care providers can now administer the bivalent doses to these age groups.

Related News Articles

Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…
Headline
Fewer than one in four health care professionals working in acute care hospitals and nursing homes were up to date with COVID-19 vaccination during the 2022-23…
Headline
Children under age 12 should receive a 0.25 milliliter dose of the 2023-24 Moderna COVID-19 vaccine, not the full vial for that age group, the Food and Drug…